Royal Bank Of Canada Genetic Technologies LTD Transaction History

Royal Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.0 - $0.01 $0 - $9	992 Added 12400.0%	1,000 $1,000
Q4 2021 Feb 14, 2022	SELL	$0.0 - $0.01 $0 - $29	-2,992 Reduced 99.73%	8 $0
Q3 2021 Nov 15, 2021	BUY	$0.0 - $0.01 $0 - $30	3,000 New	3,000 $9,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $21.5M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.